Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hebei Ziweishan Hemodialysis Concentrated Powder is a medical product used to prepare dialysate for patients undergoing hemodialysis, primarily for the treatment of chronic kidney disease and renal failure. Manufactured by Hebei Ziweishan Pharmaceutical Co., Ltd., the product is a high-purity electrolyte mixture designed to meet ultra-pure dialysate standards. It is available in multiple formulations, including high-calcium, low-calcium, high-potassium, and glucose-containing variants, to address specific patient electrolyte and metabolic needs. The powder is characterized by low acetate content and high safety, making it suitable for long-term dialysis. In China, it is regulated as a Class III medical device.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hebei ziweishan hemodialysis concentrated powder.